Treatment of multiple sclerosis with oral cladribine: results of clinical trials

Abstract

Cladribine tablets has been registered recently for treatment of relapsing multiple sclerosis. The article presents results of thepivotal clinical trial CLARITY and its extension - efficacy of cladribine tablets on clinical and radiological outcomes, and safetyand tolerability data

Keywords

• multiple sclerosis
• cladribine